Skip to main content
Clinical Trials/IRCT20210515051307N2
IRCT20210515051307N2
Recruiting
Phase 3

Evaluation of efficacy, satisfaction, and complication of fractional carbon dioxide laser treatment with platelet-rich plasma in comparison with fractional carbon dioxide laser alone in the treatment of burn scars

Skin and Stem cellResearch Center of Tehran University0 sites20 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Burn scar.
Sponsor
Skin and Stem cellResearch Center of Tehran University
Enrollment
20
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Skin and Stem cellResearch Center of Tehran University

Eligibility Criteria

Inclusion Criteria

  • Patients with skin type 1\-4
  • Patients with atrophic burn scars in more than one limb, from five years ago to the last 3 months

Exclusion Criteria

  • Age under 18 years.
  • Patients who have received laser treatment in the last three months
  • Patients with active colloidal scar or active skin lesion at the injection site
  • Patients with coagulation and platelet disorders
  • Patients with a history of taking anticoagulants
  • Patients with a history of underlying diseases such as diabetes and autoimmune connective tissue disease that affect the wound healing process
  • Patients with active viral infections
  • History of malignancy or receiving chemotherapy
  • Pregnancy and lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials